Publication2019
Nanoceria: A rare-earth nanoparticle as a promising anti-cancer therapeutic agent in colon cancer
The record
- Type
- Publication
- Date
- 1 December 2019
- Level
- National
- Journal
- Materials Science in Semiconductor Processing
- Volume
- 104
- Published
- 1 December 2019
- DOI
- 10.1016/j.mssp.2019.104669
- Scopus ID
- 85070826574
- ISSN
- 13698001
- Authors
- 8
- Open access
- No
- Citations
- 22
- International co-authorship
- No
- Co-author countries
- IN
Classification
Every label below carries the reasoning it was assigned on, the confidence band it was assigned in, and what produced it. The rubric is published.
UN Sustainable Development Goals
3.4 Reduce premature mortality from non-communicable diseases and promote mental health and well-being
CeO2 nanoparticles synthesized via microwave combustion demonstrate differential cytotoxicity and apoptotic mechanisms in colon cancer cells versus healthy cells.
- High confidence
- The subject matter is a strong and direct inference from the record type, the funding or organising body, or the programme context, even where the title alone is thin. Example: an ICMR-funded project against SDG 3, on the strength of the agency.
- Judged
- Judged against the published classification rubric, under the rubric and prompt versions recorded with the run that produced it.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
9.5 Enhance scientific research, upgrade technological capabilities, and increase researchers and R&D spending
Nanoceria synthesis methodology and anti-cancer therapeutic mechanism research advances nanomedicine and cancer drug development.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Viksit Bharat @2047
vb-1.2 Health and well-being
Cancer therapeutic innovation using rare-earth nanoparticles contributes to precision medicine and improved health outcomes.
- Produced by
- claude-haiku-4-5-20251001, under kortex-publication-v1
Each label above carries the instrument and the version that produced it. How each classification is reached.
Evidence
Kortex hosts no documents. Evidence is an outbound link to the authority that holds it.
No outbound evidence link is recorded for this activity. The record below states which source it came from and when it was last read.
Provenance
Which source system this record came from, how many source rows were resolved into it, and when each was last read.
- Source rows resolved into this record
- 1
Each record carries the date Kortex last read it from its source system. That is a freshness date and not a verification: Kortex records what its sources say and when it read them, and it does not check those statements against any external authority. No claim on this site is described as verified, because none is.
Citing this record
This URL is stable. A record’s permalink is frozen when it is published and is not regenerated if its title is later corrected.
KIIT Deemed to be University. “Nanoceria: A rare-earth nanoparticle as a promising anti-cancer therapeutic agent in colon cancer”. Kortex.